Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Concomitant administration of glucocorticoid receptor modulators and CYP3A inhibitors

Concomitant administration of glucocorticoid receptor modulators and CYP3A inhibitors

US Patent 10842800 · Granted Nov 24, 2020

Estimated economic value: $24,227,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Fatty liver disease treatment using glucocorticoid and mineralocorticoid recepto2025
Intermittent dosing of glucocorticoid receptor modulators for the treatment of o2024
Concomitant administration of glucocorticoid receptor modulators and CYP3A inhib2024
Concomitant administration of glucocorticoid receptor modulators and CYP3A inhib2024
Methods of treating antipsychotic-induced weight gain with miricorilant2024
Use of glucocorticoid receptor antagonists in combination with glucocorticoids t2024
Fatty liver disease treatment using glucocorticoid and mineralocorticoid recepto2023
Methods for treating Cushing's syndrome2022
Use of glucocorticoid receptor antagonists in combination with glucocorticoids t2021
Optimizing mifepristone levels for Cushing's patients2021
Treatment of muscular dystrophy2021
Fatty liver disease treatment using glucocorticoid and mineralocorticoid recepto2021